ATEM (Alvesco non-interventional study) - ATEM
Study identifier:CL-9709-401-DE
ClinicalTrials.gov identifier:NCT01147224
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Alvesco for the therapy of persistent asthma with or without allergic component
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
Alvesco
Sex
All
Actual Enrollment
400
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2010
Primary Completion Date: 01 May 2011
Study Completion Date: 01 Aug 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| ATEM A prospective one-arm non-interventional study with asthma patients treated with Alvesco. | Drug: Alvesco This is an observational study. Therefore, the physician decides about dosage according to individual needs. Other Name: Ciclesonide |
Contacts
Investigators
Principal Investigator
AstraZeneca AstraZeneca
AstraZeneca
